Basic Search
|
Geographic Searches
|
Advanced Search |
MegadealsSubsidy Tracker: Industry Summary Page
Major Industry: pharmaceuticals
Subsidy Total: $3,972,211,621
Number of Awards: 2,783
Time Period: Earliest year of data: 1975. Availability of data for earlier years varies greatly from program to program. The majority of the listings for this industry are for the period since 2012.
Notes: The dollar total above adjusts for the fact that there is an overlap between the amounts in one or more Megadeal entries and those of one or more of the other entries. The total includes only those entries matched to a parent company. The industry designation is the primary one for the parent's operations overall. Dollar totals do not include awards for which no subsidy value is disclosed.
Top 10 Parent Companies | Total Subsidy $ | Number of Awards |
Eli Lilly | $601,741,368 | 77 |
Regeneron Pharmaceuticals | $469,433,071 | 112 |
AstraZeneca | $436,175,713 | 52 |
Pfizer | $332,313,011 | 206 |
Novo Holdings A/S | $241,475,902 | 102 |
Elanco Animal Health | $189,545,200 | 7 |
Merck | $153,889,367 | 82 |
AbbVie | $145,729,008 | 68 |
Johnson & Johnson | $111,279,431 | 124 |
Bristol-Myers Squibb | $110,616,473 | 81 |
Individual Subsidy Records:
Warning: Attempt to read property "post_title" on string in
/usr/home/goodjobsfirst/public_html/subsidytrackerlive/function.php on line
2057
Warning: Attempt to read property "post_name" on string in
/usr/home/goodjobsfirst/public_html/subsidytrackerlive/function.php on line
2059
Company | Parent | Location | Subsidy Source | Year | Subsidy Value | Loan/Bailout Value | Type of Subsidy |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2012 | $92,277 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2013 | $512,604 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2013 | $512,604 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2013 | $512,604 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2014 | $1,257,792 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2014 | $1,257,792 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2014 | $1,257,792 | | enterprise zone |
ImClone Systems Corporation | Eli Lilly | New York | state | 2011 | $574,259 | | enterprise zone |
ImClone Systems LLC | Eli Lilly | New York | state | 2012 | $901,984 | | enterprise zone |
Pfizer, Inc. | Pfizer | New York | state | 2005 | $500,000 | | enterprise zone |
Pfizer, Inc. | Pfizer | New York | state | 2002 | $2,783,900 | | enterprise zone |
Pfizer, Inc. | Pfizer | New York | state | 2003 | $2,956,000 | | enterprise zone |
Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals | New York | state | 2008 | $1,152,412 | | enterprise zone |
Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals | New York | state | 2009 | $363,019 | | enterprise zone |
Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals | New York | state | 2010 | $143,721 | | enterprise zone |
Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals | New York | state | 2011 | $153,972 | | enterprise zone |
Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals | New York | state | 2012 | $146,985 | | enterprise zone |
Regeneron Pharmacueticals, Inc. | Regeneron Pharmaceuticals | New York | state | 2004 | $653,700 | | enterprise zone |
Regeneron Pharmacueticals, Inc. | Regeneron Pharmaceuticals | New York | state | 2003 | $4,885,774 | | enterprise zone |
SYNTHES (U.S.A.) | Johnson & Johnson | New York | state | 2004 | $1,130,588 | | enterprise zone |
SYNTHES (U.S.A.) | Johnson & Johnson | New York | state | 2005 | $1,985,000 | | enterprise zone |
SYNTHES (U.S.A.) | Johnson & Johnson | New York | state | 2003 | $939,077 | | enterprise zone |
SYNTHES U.S.A., LLC | Johnson & Johnson | New York | state | 2008 | $2,196,897 | | enterprise zone |
SYNTHES U.S.A., LLC | Johnson & Johnson | New York | state | 2009 | $2,600,000 | | enterprise zone |
SYNTHES U.S.A., LLC | Johnson & Johnson | New York | state | 2010 | $1,980,000 | | enterprise zone |
SYNTHES U.S.A., LLC | Johnson & Johnson | New York | state | 2001 | $620,000 | | enterprise zone |
SYNTHES U.S.A., LLC | Johnson & Johnson | New York | state | 2002 | $828,938 | | enterprise zone |
SYNTHES U.S.A., LLC | Johnson & Johnson | New York | state | 2011 | $2,366,358 | | enterprise zone |
SYNTHES U.S.A., LLC | Johnson & Johnson | New York | state | 2012 | $1,457,431 | | enterprise zone |
SYNTHES U.S.A., LLC | Johnson & Johnson | New York | state | 2013 | $2,311,702 | | enterprise zone |
SYNTHES U.S.A., LLC | Johnson & Johnson | New York | state | 2014 | $1,028,677 | | enterprise zone |
Abbott Laboratories | Abbott Laboratories | Ohio | state | 2019 | undisclosed | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2016 | $5,514,595 | | enterprise zone |
AMRI Rensselaer, Inc. | Curia Inc. | New York | state | 2016 | $67,627 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2017 | $1,583,114 | | enterprise zone |
Ethicon, Inc. | Johnson & Johnson | Texas | state | 2019 | undisclosed | | enterprise zone |
Abbott Laboratories | Abbott Laboratories | Texas | state | 2020 | undisclosed | | enterprise zone |
Idexx Laboratories, Inc. | IDEXX Laboratories | Maine | state | 2021 | $2,334,260 | | enterprise zone |
Idexx Laboratories, Inc. | IDEXX Laboratories | Maine | state | 2019 | $1,954,481 | | enterprise zone |
Idexx Laboratories, Inc. | IDEXX Laboratories | Maine | state | 2020 | $1,927,300 | | enterprise zone |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,524 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,524 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,524 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,524 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,550 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,550 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,550 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,550 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,675 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,675 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,675 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,675 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $11,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $11,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $11,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $11,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $15,400 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $15,400 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $15,400 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $15,400 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $19,463 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $19,463 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $19,463 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $19,463 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $32,600 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $32,600 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $32,600 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $32,600 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $7,800 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $7,293 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $7,200 | | cost reimbursement |